Enzyre is a series a startup. 1 investor tracked on Brouky Intelligence. Status: possibledead. Data sourced from Brouky Intelligence.
About
Enzyre develops diagnostic products for point-of-care testing. Their technology enables rapid blood coagulation analysis, providing immediate insights for critical care and thrombosis management.
Stage
series-a
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky